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Summary.-By means offlow cytometric recording of DNA histograms and counting
of cells in synchronized populations, we have found that misonidazole (MIS) in
clinically relevant concentrations induces cell-kinetic changes in human cells (NHIK
3025) cultivated in vitro under aerobic conditions. The effect seems to be a general
lengthening of the cell cycle, affecting all phases. However, induction of this effect is
phase-dependent, since only cells exposed to MIS during mitosis and/or early Gl
will suffer significant cell-cycle prolongation.
In exponentially growing populations this effect of MIS leads to a transient increase
in the fraction of Gl cells and a corresponding decrease in the fraction of S cells. The
possible significance of this effect for the clinical use of MIS is discussed.
MISONIDAZOLE (1-(2-nitroimidazol-1-yl)-
3-methoxy-2-propanol, formerly Ro-07-
0582, here abbreviated to MIS) is currently
tested as an adjunct to radiotherapy in
humans (Thomlinson et al., 1976; Dische
et al., 1977). Apart from its radiosensi-
tizing effect on hypoxic cells, MIS has
been found to have a cytotoxic effect
which is stronger under hypoxic than
under aerobic conditions (Hall & Roizin-
Towle, 1975; Moore et al., 1976; Stratford,
1978; Taylor & Rauth, 1978).
While the cytotoxic effects of MIS have
been studied both in vitro (Hall & Roizin-
Towle, 1975; Moore et al., 1976; Stratford
& Adams, 1977) and in vivo (Brown, 1975),
little information is so far available on
explicit cell-cycle-inhibitory effects. It has
been shown (Stratford & Adams, 1977;
Miller & Hall, 1978) that cell growth,
scored as increase in cell number with
time, was almost zero in populations ex-
posed to 5 mm MIS under aerobic condi-
tions. Geard et al. (1978) have reported
data on the rate of metaphase accumula-
tion for exponentially growing Chinese
hamster V79 cells in contact with MIS and
inhibited in metaphase with colcemid.
Accumulation was followed up to 6 h after
addition of MIS, without any inhibitory
effect under aerobic conditions being seen.
In hypoxic cells, however, MIS slowed
down progression through the cell cycle
in a manner nonspecific for cell-cycle
stage.
The present investigation shows that
exposure to MIS under aerobic conditions
has cell-cycle-inhibitory effects in human
NHIK 3025 cells cultivated in vitro.
MATERIALS AND METHODS
For this study exponentially growing as
well as synchronized populations of the
established human cell line NHIK 3025 were
used (Nordbye & Oftebro, 1969; Oftebro &
Nordbye, 1969). Cultivated in medium E2a
(Puck et al., 1957) supplied with 20% human
serum and 10% horse serum, these cells have
a doubling time ofabout 18 h (Pettersen et al.,
1977). The median generation time in popu-
lations synchronized by mitotic selection has
been determined as 17-5-18-0 h. Correspond-
ing durations of the various phases were:
GI 6 5 h, S 8.0-8.5 h, G2+M 2-5-3.5 h
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(Pettersen et al., 1977; Lindmo & Pettersen,
1979).
For the present study synchronized popu-
lations of NHIK 3025 cells were obtained by
repeated mitotic selection from exponentially
growing populations cultivated in 75cm2
Falcon plastic flasks (Pettersen et al., 1977).
MIS (kindly supplied by Roche Products Ltd,
U.K.), dissolved in Medium E2a to various
final concentrations, was added to the cells by
changing the medium either 45 min before or
2 h after mitotic selection. When MIS was
added 2 h after selection (i.e. after the cells
had attached to the bottom of the tissue
culture flask) the control population received
fresh, drug-free medium.
To determine the generation time of drug-
treated populations, the increase in cell
number was measured with an inverted
phase-contrast microscope by counting the
number ofcells within delineated areas on the
bottom of the culture flasks. The effects of
MIS on the cell-cycle progression of syn-
chronized populations were investigated by
taking samples at different times for flow-
cytometric measurement ofDNA histograms.
All the above experimental procedures were
in an incubator room at 37 +0 2°C.
Single-cell suspensions for flow cytometric
DNA measurement were obtained by trypsin
treatment (0 25% trypsin, Difco, 1: 250) and
subsequent washing in Hanks' solution. Cells
were stained for DNA measurement without
previous fixation, using the DNA-specific
stain mithramycin (Mithracin, Chas. Pfizer
& Co. Inc.) according to the procedure by
Crissman & Tobey (1974).
DNA histograms were recorded on a
laboratory-built flow cytometer (Lindmo &
Steen, 1977; Lindmo & Pettersen, 1979).
Fluorescence from mithramycin was excited
with the 457*9nm line of a 4W Argon laser
and measured at wavelengths longer than
476 nm. To aid in the interpretation ofregis-
tered DNA histograms, the median channel
position was calculated for histograms of
synchronized populations (Lindmo & Petter-
sen, 1979).
To investigate the inactivating effect of
MIS, NHIK 3025 cells were plated in Petri
dishes and exposed to various concentrations
of MIS for 24 h. After rinsing, the cells were
incubated in fresh, drug-free medium for
12-14 days to determine the fraction of
surviving cells as expressed by their ability
to form colonies.
RESULTS
Cell survival after 24h exposure to
different concentrations of MIS is shown
in Fig. 1. Up to 1 mm, cell survival was
about 90%, but cell inactivation became
significant at higher concentrations.
The generation time for synchronized
populations exposed to different concen-
trations of MIS from 45 min before or 2 h
after mitotic selection can be estimated
from the growth curves in Fig. 2. When
1mM MIS was added before selection
(Panel A), the cells showed a significant
cell-cycle prolongation during the first
generation. This did not occur, however,
when the drug was added 2 h after mitotic
selection (Panel B). Thus significant cell-
cycle prolongation is only induced by MIS
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FIG. 1.-Surviving fractions of exponentially
growing populations of NHIK 3025 cells
incubated for 24 h in the presence of
various concentrations of MIS. Different
symbols represent independent experi-
ments. The line is drawn between mean
values at each concentration.
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FIG. 2. Relative increase in cell number as a
function of time in synclironized popula-
tions of NHIK :3025 cells exposed to
various concentrations of AIIS from 45 mimi
before (A) or 2 h aifter mitotic selection (B).
Different symbols (O, A, O andl O) repie-
senIt lifferent concentrations of MIS
(control, I mai, 2 mAi aindl 4 mr3 res-
pectively). These resuilts an(l the flow-
cytometric (lata in Figs 3 & 4 Nwere
obtainie(d from independlent experiments.
when the drug is present during mitosis
or the beginning ofG(1. Therefore, when the
drug was added 2 h after mitotic selection
(i.e. after the cells had passed the critical
stage), no significant effect was induced
CONTROL
until the cells passed through mitosis/
early GI in the presence of the drug after
the first cycle (Fig. 2B). For 2 mm MIS the
results were in general agreement with the
above pattern, but cell inactivation and
cell loss during mitosis were no longer in-
significant, and for 4 mat such effects
dominated the results.
Fig. 3 shows DNA histograms of
synchronized cell populations trypsinized
and stained 10 h after mitotic selection.
MIS was added 45 min before mitotic
selection in concentrations of 0 8 and 2
mM. In the population exposed to the
latter concentration, a large fraction of
the cells was still in G1 10 h after selection,
while in the control population the G1
compartment was nearly depleted of cells.
Cells exposed to 0-8 mm were also signifi-
cantly delayed compared to the control
population.
Fig. 4 shows DNA histograms of popu-
lations treated wvith the same concentra-
tions of MIS as for Fig. 3, but in this case
the drug was added 2 h after mitotic
selection. At 19 h after mitotic selection,
cell division was almost completed in the
control as well as in the drug-treated
populations, in agreement with the results
of Fig. 2B. Thus, even the population
exposed to 2 mmi MIS was not significantly
0.8mM 2.0mM
FIG. 3. DNA li,stograms of synchronized populations of NHIK :3025 cells trypsinize(d and stainie(l
10 Ii after mitotic selection. Along the top are in(dicated the concentrations of M\IIS, fIom 45 n1i)?
before mtitotic selectioni. 40,000 cells were registerecd for each hiistogiam. In eachi panicl, the abscissa
shiows clhannel nriumber in sub(livisions of 10 from 0 to 120 (proportiotial t,o celltular D.NA contenit).
The ord(inate slhows the nimberi of cells registeredl per chiannel in stubclivisions of 1000 cells.
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FIG. 4. DNA histograms of synclhronized populations of NHIK 3025 cells trypsinized and stained
at indicated times after mitotic selection. Along the top are indicated the concentrations of MIS
from 2 h after mitotic selection. Other details as in Fig. 3.
delayed by the I7h drug treatment from
GI through the rest of the first cell cycle.
However, after exposure to MIS during
the sensitive stage in mitosis/early GI after
the first generation, the rate of cell cycle
progression was reduced. Thus, at 28 h
after mitotic selection, the population
exposed to 0 8 mm had not yet reached
the stage represented by the control
population at 25 h. Most of the cells
exposed to 2 mm were still in GI of the
second generation.
DISCUSSION
The present results show that under
aerobic conditions MIS induces cell-cycle
inhibition in the human cell line NHIK
3025. Without causing cell inactivation
(Fig. 1) or cell loss during division (Fig. 2),
a concentration of 1mM MIS leads to a
significant kinetic effect which appears as
a reduced rate of progression through the
cell cycle. Induction of this effect occurs
only at a certain stage of the cell cycle.
Only cells exposed to MIS while in mitosis
or in early GI will suffer a significant re-
duction in cell-cycle progression rate.
A quantitative comparison of the DNA
histograms in Fig. 3 with a time series of
control histograms indicates that the
population exposed to 0-8 mM from 45 min
before mitotic selection lagged about h
behind the control population at 0 h. The
:= .*....-.*-..s
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results of Fig. 2A show that the delay at
the end of the first cycle (18 h) was nearly
2 h for the lower concentration. At the end
of the second generation the delay was
more than 4 h, as judged from Fig. 2A.
The cell-cycle prolongation induced by
MIS therefore seems to be due to a re-
duced rate of cell-cycle progression rather
than a temporary block at a certain stage
of the cell cycle.
CGrowth curves (Fig. 2B) as well as DNA
histograms (Fig. 4), which were obtained
from independent experiments, demon-
strated no effect of 1 mm MIS during the
first generation when the drug was added
2 h after mitotic selection, but at the end
of the second generation cell division was
delayed about 3 h (Fig. 2B). Analysis of
the flow-cytometric results (Fig. 4) indi-
cated a 3h delay by the middle of the
second cycle. These values are larger than
the delay seen during the first cycle when
MIS was added before mitotic selection.
Thus the sensitivity to MIS in the critical
period around mitosis and early Gl may
be higher when the drug has been present
during the preceding interphase.
It is difficult to determine whether the
durations of the various phases are pro-
longed by the same factor as a result of
exposure to MIS, i.e. whether the pro-
gression rate is uniformly reduced over
the whole cell cycle. Analyses of series of
DNA histograms complementary to those
shown in Figs 3 & 4 clearly showed that
GI as well as S were prolonged after drug
treatment. Owing to the short duration of
G2 and mitosis, and the deterioration in
synchrony with time after mitotic selec-
tion, the prolongation of G2 and mitosis
was difficult to assess. However, the cell-
cycle distribution ofexponentially growing
populations which had been exposed to
MIS for the whole of one cycle was found
to be similar to that of untreated control
populations (see below). This finding sup-
ports the interpretation that MIS re-
duces the rate of progression uniformly
over the cell cycle.
Geard et al. (1978) showed that MIS in
concentrations of 5 mm had no effect on
the rate of entry into mitosis of aerated
exponentially growing Chinese hamster
V79 cells. Their investigation considered
only the first 6 h after drug administra-
tion. Effects such as those described in
this report would, however, influence the
rate of entry into mitosis only after a time
comparable to the normal cell-cycle time.
At that time cells which were just past the
sensitive stage at the moment of drug
addition would have reached mitosis after
a normal cell cycle. The rate of entry into
mitosis would then be low until the first
cells to traverse the whole cell cycle at a
reduced rate were entering mitosis. Thus,
upon addition of MIS a gap will arise
between the last cells to escape the effect
in mitosis/early G1 and the first cells to
traverse the cell cycle at a reduced rate.
As this increasing gap is propagated
through the cell cycle, transient changes
in the cell-cycle distribution will occur.
The first manifestation of this effect will
be an increase in the G1 fraction of the
cell population and a corresponding de-
crease in the S fraction, caused by a
period of reduced rate of cell transit from
G1 to S.
By flow-cytometric measurement of
DNA histograms, such transient changes
were demonstrated in exponentially grow-
ing populations of NHIK 3025 cells ex-
posed to various concentrations of MIS.
Compared to the normal cell-cycle dis-
tribution of 450 G1, 35% S, and 20%
G2+M, the fraction of GCl cells increased
by a factor of 1P4 between 6 and 12 h after
addition of 2 mm MIS and there was a
corresponding reduction in the fraction of
S cells by a factor of 0 5. For 1 mm the
differences were smaller (i.e. increase in
GI by a factor 12, and decrease in S by a
factor 0.7). After 24h drug treatment, the
fraction of cells in Gx1 and S had again
resumed normal values, presumably be-
cause the whole population by then had
assumed a uniformly slower proliferation
rate.
The effects of MIS here presented were
induced by a drug treatment which, in
terms of both MIS concentration and
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exposure time, is relevant for clinical
applications. Plasma concentrations up to
1 mM have been achieved without severe
neurotoxic side effects (Kogelnik et al.,
1978) and the biological half-life of MIS is
10-18 h in human plasma (Dische et al.,
1977, 1978).
When MIS is used as a radiosensitizer of
hypoxic cells in clinical radiotherapy, it
may possibly induce in vivo cell-kinetic
effects on aerobic cells comparable to those
described here. Since the radiosensitivity
of many cell types varies through the cell
cycle, a change in the cell-cycle distribu-
tion will affect the overall radiosensitivity
of the tissue. Many cell types are more
resistant to radiation in G1 than in S
(Sinclair, 1968). If aerobic proliferative
normal tissue exhibits similar differential
radio-resistance in G1, transient changes
in the cell-cycle distribution as described
above, if present in vivo after clinical
administration of MIS, will lead to an
increased resistance to radiation a certain
time after drug addition. In principle such
an effect might be utilized to reduce the
radiation damage to the normal tissue
within the radiation field. This would be
achieved by applying the radiation when
the shift in cell-cycle distribution of the
normal tissue, and thus the change in its
radiosensitivity, offered the largest pro-
tective effect. However, even for the most
favourable case of high differential radio-
resistance in G 1, the increase in cell
survival will be relatively small, since it
will never exceed the increase in the
resistant fraction of the cell population.
This work was supportedi by the Norwegian
Cancer Society-Landsforeningen mot Kroft, of
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